FDA NDC Directory · JSON-LD · Markdown

Actemra

NDC 50242-138 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nametocilizumab
Labeler / ManufacturerGenentech, Inc.
Marketing categoryBiologic License Application · App BLA125472
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsTOCILIZUMAB (162 mg/.9mL)
Marketing started20131021
Package count2

External sources

Source: openFDA. Public-domain (CC0).